708 - Raising the bar of efficacy in atopic dermatitis: lebrikizumab maintains depth of response over 2 years
Year: 2024
Type: article
Source: British Journal of Dermatology
Institutions: Oregon Health & Science University, Technical University of Munich, Icahn School of Medicine at Mount Sinai, Rosalind Franklin University of Medicine and Science, Bellvitge University Hospital, Universitat de Barcelona, Eli Lilly (United States), Almirall (Spain), Aarhus University Hospital
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4401436094
